SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials
Lancet 2020 Aug 28;[EPub Ahead of Print], F Zannad, JP Ferreira, SJ Pocock, SD Anker, J Butler, G Filippatos, M Brueckmann, AP Ofstad, E Pfarr, W Jamal, M PackerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.